Скачайте изображение (превью) выбрав качество

320x180 480x360 640x480 1280x720

Watch on Radcliffe Cardiology:

In this interview recorded at Heart Failure 2022, Dr Joanna Osmanska (University of Glasgow, UK) outlines the findings of the SUBCUT-HF I and the SQI 01-01 studies.
The studies, presented at Heart Failure 2022, demonstrated that the novel subcutaneous furosemide resulted in similar efficacy in terms of diuresis and natriuresis when compared to intravenous furosemide.
In addition to this the subcutaneous administration of novel preparation of furosemide with custom-made patch pump was feasible and well tolerated by patients.

Discussion Points:
1. Importance of this Study
2. Investigational Product
3. Study Design and Eligibility Criteria
4. Key Findings
5. Take-Home Messages
6. Next Steps

Recorded on-site at Heart Failure 2022, Madrid.

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.

Чтобы скачать видео "HF 2022: Novel Patch Infusor Device & Subcutaneous Furosemide in Pts with HF | Dr Joanna Osmanska" передвинте ползунок вправо